We have updated our terms and conditions and privacy policy
Click “Continue” to accept and continue with ET HealthWorld
Dear user,
ET HealthWorld privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website.
You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website.
If you choose to ignore this message, we’ll assume that you are happy to receive all cookies on ET HealthWorld.
NIV’s Mumbai team uses CRISPR to develop poliovirus-free cell line
India adds 21,411 COVID-19 cases, 67 deaths
Rebooting Cancer Awareness
The unsung hero in faster holistic recovery
Technological Disruption in Indian Health & Pharma
Do you think you are up for the challenge?
Holistic Solutions For A Healthier India
17 July
Adopting-Dynamic-Technologies
Merck’s first Microbiology Application and Training Lab in India that supports capability built-up in microbial quality control in Pharma, and biopharma industry. Merck invests €200,000 in the infrastructure of the new lab at Jigani.
Recommended by Colombia
125000+ Industry Leaders read it everyday
Pharmacists in Gujarat have geared up to give a tough fight to online medicine retailers by enabling people to get medicines at their doorsteps at competitive prices.
The growing anti-diabetes market, valued at about Rs 17,000 crore, is set to witness action with generic versions of US firm Merck’s blockbuster Januvia being launched, reducing the cost of therapy by a third. This is on the heels of Sitagliptin, a relatively newer but vital anti-diabetic drug, losing patent protection in July.
We have various options to advertise with us including Events, Advertorials, Banners, Mailers, Webinars etc.
Please contact us to know more details.
Get ETHealthworld‘s top stories every morning in your email inbox.
125000+ Industry Leaders read it everyday
Follow @ETHealthworld for the latest news, insider access to events and more.
